NDAORALFOR SUSPENSION
Approved
Aug 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Mechanism of Action
[see Microbiology ( )] .
Indications (14)
the following infections in adultsskin structure infections Urinary tract infections Limitations of Useindicating no beta-lactamase productionAmoxicillinClavulanate Potassium should not be useddevelopment of drug-resistant bacteriamaintain the effectiveness of AmoxicillinClavulanate Potassiumother antibacterial drugsClavulanate Potassium should be used only to treatprevent infectionsstrongly suspected to be caused by bacteriadevelopment of drug‑resistant bacteriastrongly suspected to be caused by susceptible bacteria